Lincoln National Corp’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,739
Closed -$380K – 676
2024
Q1
$380K Buy
1,739
+411
+31% +$90.5K 0.01% 857
2023
Q4
$302K Buy
+1,328
New +$279K 0.01% 867
2023
Q3
– Sell
-1,114
Closed -$231K – 1053
2023
Q2
$231K Buy
1,114
+11
+1% +$2.13K ﹤0.01% 902
2023
Q1
$218K Buy
1,103
+1
+0.1% +$206 ﹤0.01% 895
2022
Q4
$223K Buy
+1,102
New +$215K 0.01% 832

Other funds holding LH

Lincoln National Corp's LH Position: Q2 2024 in Review

Lincoln National Corp sold out of Labcorp (LH) in Q2 2024, closing a stake of 1,739 shares — an estimated $380K sold.

Lincoln National Corp first reported a position in LH in Q4 2022 and held it in 5 quarters. The position peaked at $380K in Q1 2024. 854 funds tracked by Wall St. Rank hold LH as of Q2 2024.

  • Lincoln National Corp reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 1,739 Labcorp shares in Q2 2024, an estimated $380K.
  • Lincoln National Corp first reported a position in Labcorp in Q4 2022 and held it in 5 quarters.
  • Lincoln National Corp's Labcorp position peaked at $380K in Q1 2024.
  • 854 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.